T2DM Flashcards
(38 cards)
What happens
Reduced Insulin sensitivty
Beta cell dynfction
Causes for reduced insulin sensitivity
Obesity
Inflammation
Lipotoxiciyty
Which Hba1c reflect a diagnosis
Hba1c 48>
If hba1c is hard to interpret
What fasting glucose are we looking for
> 7
Which random plasma glucose reflects T2DM
> 11
How often is hbalc monitored
3-6 months, then every 6 months
Clincal features
Similar to type 1
But slower onset
Ancanthosis nigricans can be a hallmark for type 2 - what does it look like
Dark pigmentation of skin folds in groin and neck - suggest insulin resistance
Targets for those on a single drug not linked which typos
<48
Targets for those on multiple drugs not accosated with hypos
53
Targets for those on a single drug causing hypos
53
Which drugs are linked with hypos
Insulin
Sulfonylureas - gliclazide (all end in ide)
In type 1 theire is frequent monitoring of capillaries blood glucose conc, if this required in type 2
No
When maybe it be required in type 2
Pregnant
On insulin
On a drug which causes hypos
What is the hba1c target for those silent on life style interventions
48
1st line if no HF, CVD, or CVD risk
Metformin
If they Cannot tolerate metformin
DPP4
Then pioglitazine or sulfonylurea
Then SGLT2 inhibitor (if pio or sulf are CI due to hypos)
1st if CHF, CVD or qrisk over 10%
Metofmrin THE once tolerated then SGLT2 inhibitor
If CHF, CVD or qrisk over 10% and metformin and SGLt2 doesn’t work, what would be added
DPP4 inhibitor
Or
Pioglitazine or sulfonurea
Or insulin - as the third drug
If on Triple therapy and still ineffective
Switch non-metformin drug for a GLP-1 against (semaglutide)
Eg. Metformin + suflonurea + GLP-1 agonist
What are the requirements for prescribing GLP-1 against
bmi over 35 + physiological or med probs linked with diabetics
BMI less then 35 and insulin would have an occupational impact - driver, piolet
Which drugs increase insulin sensitivity
Metformin and pioglitazone
Which drugs increase insulin secretion
DPP4 inhibitor
GLP1 agonist
Sulphonylureas
Which drug blocks reabsorption of glucose in the proximal tubule
SGLT2 inhibitors